TRDA R&D Expenses

Entrada Therapeutics Inc · R&D Expenses

TRDA logo

TRDA R&D Expenses

Latest reported$140.74M
TRDA TTM R&D Expenses ($21.10M → $140.74M)
High-resolution chart · PNG

TRDA r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Entrada Therapeutics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
140,741,000
143,249,000
142,269,000
141,718,000
134,614,000
128,772,000
125,306,000
120,191,000
111,125,000
105,390,000
99,884,000
87,278,000
84,045,000
73,993,000
66,609,000
63,286,000
54,841,000
45,422,000
35,927,000
30,221,000
25,408,000
22,952,000
21,102,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.